11th December 2024 – River Biomedics

Home
Drug Discovery
Technology
About Us
Publications
News
Career
Contact

Home
Drug Discovery
Technology
About Us
Publications
News
Career
Contact

Day

December 11, 2024

11

Dec

First-in-Class Disease-Modifying Approach to Heart Failure

11th December 2024riverbiomedicsNews

About Us

River BioMedics is a Dutch biotech company focused on cardiac drug discovery.

Recent Posts

Milestone Achieved: We’ve successfully identified active compounds in our 2D cardiomyocyte assay.
First-in-Class Disease-Modifying Approach to Heart Failure
CEO Nicky Cooper, attending BioFIT 2024 conference on 3rd/4th December.
Annual Consortium Meeting of the BioRobot-Mini Heart Project

RIVER BIOMEDICS 2021, ALL RIGHTS RESERVED, KVK 71357637